These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8475571)

  • 21. Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.
    Lirtzman RA; Gregory CR; Levitski RE; Griffey SM; Yeh LS; Patz JD; Morris RE
    Transplant Proc; 1996 Apr; 28(2):945-7. PubMed ID: 8623474
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.
    Fujishiro J; Kudou S; Iwai S; Takahashi M; Hakamata Y; Kinoshita M; Iwanami S; Izawa S; Yasue T; Hashizume K; Murakami T; Kobayashi E
    Transplantation; 2006 Sep; 82(6):804-12. PubMed ID: 17006328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
    Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
    Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac allograft tolerance induction with limited immunosuppression.
    Cohen DS; Fisher RA; Tarry WC; Tawes JW
    J Surg Res; 1996 Mar; 61(2):355-60. PubMed ID: 8656608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
    Brattström C; Tydén G; Säwe J; Herlenius G; Claesson K; Groth CG
    Transplant Proc; 1996 Apr; 28(2):985-6. PubMed ID: 8623489
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
    Kyles AE; Gregory CR; Griffey SM; Bernsteen L; Pierce J; Lilja HS; Morris RE
    Transplantation; 2003 Apr; 75(8):1128-33. PubMed ID: 12717190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
    Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
    Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine.
    Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J
    Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
    Bîrsan T; Hausen B; Higgins JP; Hubble RW; Klupp J; Stalder M; Celniker A; Friedrich S; O'Hara RM; Morris RE
    Transplantation; 2003 Jun; 75(12):2106-13. PubMed ID: 12829920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
    Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
    Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic prolongation of rabbit renal allograft survival by cyclosporine and a prostacyclin analogue.
    Redgrave NG; Francis DM; Dumble LJ; Plenter R; Ruwart M; Birchall I; Clunie GJ
    Transplant Proc; 1992 Feb; 24(1):222-3. PubMed ID: 1539256
    [No Abstract]   [Full Text] [Related]  

  • 35. Is there a rationale to combine cyclosporin and sirolimus?
    Kahan BD
    Nephrol Dial Transplant; 1996 Jan; 11(1):21-3. PubMed ID: 8649641
    [No Abstract]   [Full Text] [Related]  

  • 36. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
    Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
    Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
    [No Abstract]   [Full Text] [Related]  

  • 37. Prolongation of islet allograft survival in mice by combined treatment with pravastatin and low-dose cyclosporine.
    Arita S; Kasraie A; Une S; Ohtsuka S; Smith CV; Mullen Y
    Cell Transplant; 2001; 10(7):639-44. PubMed ID: 11714199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
    Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
    Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
    [No Abstract]   [Full Text] [Related]  

  • 39. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
    Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S
    Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720.
    Suzuki S; Li XK; Shinomiya T; Enosawa S; Kakefuda T; Mitsusada M; Amemiya H; Takahara S; Amari M; Naoe S; Hoshino Y; Chiba K
    Transplant Proc; 1996 Aug; 28(4):2049-50. PubMed ID: 8769151
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.